المنشورات
براءة اختراع
Isoandrographolide-19-propionate for treatment of non-alcoholic fatty liver disease (NAFLD). U.S. Patent 10,064,841 B1, filed January 8, 2018, and issued September 4, 2018.
مزيد من المنشورات
